Skip to main content

Jessica Hagen

By Jessica Hagen | 02:55 pm | September 29, 2022
A J.D. Power study indicates telehealth is the preferred method among consumers for receiving certain types of medical care.
By Jessica Hagen | 07:45 pm | September 28, 2022
Rippl's mental health offering aims to provide seniors with 24/7 access to care.
By Jessica Hagen | 02:33 pm | September 28, 2022
Kaleidoscope, Surge, Optellum, Cionic and Arcascope also announce funding rounds.
By Jessica Hagen | 11:38 am | September 28, 2022
Mati Gil, CEO of AION Labs, describes how its new startup OMEC.AI came to fruition and what it aims to accomplish for drug discovery and development. 
By Jessica Hagen | 01:54 pm | September 27, 2022
  The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.  
By Jessica Hagen | 04:48 pm | September 26, 2022
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
By Jessica Hagen | 02:48 pm | September 23, 2022
A recent study found out-of-state telemedicine visits were most common with those who lived near a state border, and were largely for primary and mental healthcare.
By Jessica Hagen | 11:21 am | September 23, 2022
A recent study found patients using virtual reality while undergoing hand surgery required less anesthesia during surgery.  
By Jessica Hagen | 01:50 pm | September 22, 2022
The company will use the funding to support the commercial expansion of its product.  
By Jessica Hagen | 10:12 am | September 22, 2022
Curative is shifting from COVID-19 testing to launching a new health plan as testing needs decrease.